Leading Players in the Next Generation Sequencing Market
Next-generation sequencing (NGS) refers to large-scale DNA sequencing methods that aid in genomic discovery. The term "next-generation sequencing," sometimes known as "high-throughput sequencing," refers to a variety of current sequencing technologies. These technologies provide faster RNA and DNA sequencing than standard Sanger sequencing. The need for next-generation sequencing methods will grow as R&D activities for treatments used in the treatment of genetic disorders increase. Substantial market demand will be created as R&D investments increase and the number of studies connected to the treatment of genetic disorders among individuals grows. Governments in industrialized economies have implemented a number of programmes and laws to encourage scientists and researchers to explore treatments for chronic and rare diseases.
Leading market players of the next-generation sequencing market
Now let us have a look at some of the key market players who are contributing towards the growth of the next-generation sequencing market:
Illumina is a global leader in the development, manufacture, and marketing of life science tools and integrated systems for large-scale genetic variation and function investigation. These platforms are allowing experiments that were unthinkable just a few years ago, and they are bringing us closer to individualised medicine. With rapid technological advancements, it's more important than ever to provide solutions that are not just creative, but also flexible and scalable, as well as industry-leading support and service.
BGI, formerly the Beijing Genomics Institute, is a Chinese life sciences company headquartered in Shenzhen, Guangdong, China. BGI Genomics is the world's top provider of genomic and proteome sequencing services, with customers in over 100 countries. We provide integrated genomic sequencing and proteomic services and solutions to academic institutions, pharmaceutical companies, health care providers, and other organisations for a wide range of applications, including genetic testing and screening, basic research on human, plant, animal, and microbial species, agriculture and biodiversity preservation and sustainability, clinical research in human health, and drug discovery and development.
Agilent is a market leader in the areas of life sciences, diagnostics, and applied chemistry. Instruments, services, consumables, applications, and knowledge are provided to laboratories all around the world, allowing customers to acquire the insights they want. Agilent's experience and long-term collaboration provide them with the highest level of trust in our products. It aims to focus on the six key markets such as food, environmental and forensics, diagnostics, pharmaceutical, research, and chemical and energy.
PerkinElmer is a leading global provider of end-to-end solutions that enable scientists, researchers, and clinicians better diagnose disease, find new and more tailored pharmaceuticals, monitor the safety and quality of their food, and drive excellence in environmental and applied studies. Their experts collaborate closely with commercial, government, academic, and healthcare customers to deliver reagents, assays, instruments, automation, informatics, and strategic services that accelerate workflows, deliver actionable insights, and support improved decision making. They have an 85-year legacy of advancing science and a mission of innovating for a healthier world.
QIAGEN is the world's top sample and assay technology company. DNA, RNA, and proteins can be isolated from any biological material using sample technologies. Assay technologies are then utilised to make certain target biomolecules visible for further study, such as the DNA of a specific virus.
Pacific Biosciences of California Inc.
To give its customers the most full and accurate perspective of genomes, transcriptomes, and epigenomes, the firm develops the world's most advanced sequencing systems. Its inventors pioneered a new approach to studying DNA, RNA, and protein creation and control. We're using developments in biochemistry, optics, nanofabrication, and other fields to improve human health.